Clinical trials
Terminated Phase 2 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2021 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 2 |
| CHU de Quebec-Universite Laval | 1 |
| Eisai Inc. | 1 |
| HealthPartners Institute | 1 |
| Indiana University | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Janssen Research & Development, LLC | 1 |
| National Institute on Aging (NIA) | 1 |
| Navidea Biopharmaceuticals | 1 |
| Neurocrine Biosciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 18 |
| Alzheimer Disease | 9 |
| Schizophrenia | 3 |
| Dementia | 2 |
| Inflammation | 2 |
| Breast Neoplasms | 1 |
| Cognition Disorders | 1 |
| Diabetes Mellitus | 1 |
| Memory Disorders | 1 |
| Psychotic Disorders | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.